Journal of Pharmaceutical Analysis

metrics 2024

Advancing pharmaceutical science through innovative analysis.

Introduction

Journal of Pharmaceutical Analysis is a premier open-access journal published by ELSEVIER, dedicated to advancing the field of pharmaceutical sciences. Since its inception in 2011, this journal has become a vital resource for researchers, professionals, and students, with a focus on analytical chemistry, drug discovery, and electrochemistry, among other subjects. With an impressive impact factor reflected in its Q1 ranking across multiple categories such as Analytical Chemistry and Drug Discovery in 2023, it maintains a high standard in the dissemination of innovative research. The journal not only facilitates the sharing of significant findings but also promotes collaboration and discussion within the community, making a notable impact globally. Articles published in the Journal of Pharmaceutical Analysis are easily accessible under an open-access model, ensuring that cutting-edge research reaches a diverse audience and enhances knowledge in this critical field. As it continues to converge research from 2011 to 2024, the journal remains a cornerstone in the study of pharmaceutical evaluation, analytical methods, and their applications.

Metrics 2024

SCIMAGO Journal Rank1.07
Journal Impact Factor6.10
Journal Impact Factor (5 years)6.80
H-Index51
Journal IF Without Self6.10
Eigen Factor0.00
Normal Eigen Factor0.72
Influence1.13
Immediacy Index2.00
Cited Half Life4.40
Citing Half Life5.50
JCI2.16
Total Documents874
WOS Total Citations4263
SCIMAGO Total Citations9711
SCIMAGO SELF Citations221
Scopus Journal Rank1.07
Cites / Document (2 Years)6.09
Cites / Document (3 Years)7.50
Cites / Document (4 Years)7.69

Metrics History

Rank 2024

Scopus

Pharmacy in Health Professions
Rank #1/45
Percentile 97.78
Quartile Q1
Pharmaceutical Science in Pharmacology, Toxicology and Pharmaceutics
Rank #5/183
Percentile 97.27
Quartile Q1
Analytical Chemistry in Chemistry
Rank #5/156
Percentile 96.79
Quartile Q1
Spectroscopy in Chemistry
Rank #3/76
Percentile 96.05
Quartile Q1
Drug Discovery in Pharmacology, Toxicology and Pharmaceutics
Rank #7/157
Percentile 95.54
Quartile Q1
Electrochemistry in Chemistry
Rank #6/60
Percentile 90.00
Quartile Q1

IF (Web Of Science)

PHARMACOLOGY & PHARMACY
Rank 26/354
Percentile 92.80
Quartile Q1

JCI (Web Of Science)

PHARMACOLOGY & PHARMACY
Rank 8/354
Percentile 97.74
Quartile Q1

Quartile History

Similar Journals

JOURNAL OF PHARMACEUTICAL SCIENCES

Advancing pharmaceutical knowledge, shaping future innovations.
Publisher: ELSEVIER SCIENCE INCISSN: 0022-3549Frequency: 12 issues/year

The JOURNAL OF PHARMACEUTICAL SCIENCES, published by ELSEVIER SCIENCE INC, stands as a cornerstone in the field of pharmaceutical sciences, offering a platform for innovative research and advancements since its inception in 1961. With an impressive Scopus Rank of #36 out of 183 in the Pharmaceutical Science category, this journal is recognized for its commitment to disseminating high-quality, peer-reviewed studies that significantly contribute to the realms of pharmacology, toxicology, and pharmaceutics. Holding a 2023 Q2 category quartile, it attracts a diverse readership encompassing researchers, industry professionals, and students eager to advance their understanding and expertise. While the journal is not open access, it ensures valuable insights in every issue, making it an essential resource for those dedicated to the evolving landscape of pharmaceutical research. With an impact factor that reflects its relevance and influence, the JOURNAL OF PHARMACEUTICAL SCIENCES continues to shape the discourse in its domain, fostering innovation and collaboration among scholars worldwide.

Journal of Analytical Methods in Chemistry

Connecting theory and practice for a brighter scientific future.
Publisher: HINDAWI LTDISSN: 2090-8865Frequency:

The Journal of Analytical Methods in Chemistry, published by HINDAWI LTD, stands as a premier platform dedicated to the dissemination of research in the vibrant field of analytical chemistry. With an ISSN of 2090-8865 and an E-ISSN of 2090-8873, this Open Access journal has been committed to providing unrestricted access to quality research since 1978, thereby fostering greater collaboration and innovation among researchers, professionals, and students globally. The journal showcases rigorous research insights spanning diverse categories, earning impressive Scopus rankings including Q2 in Chemical Engineering and Q3 in Analytical Chemistry for 2023, positioning itself effectively among respected peers. Its interdisciplinary approach also covers significant contributions in the realms of instrumentation and computer science applications, thus addressing contemporary challenges and advancements in analytical methodologies. By bridging theoretical underpinnings with practical applications, the Journal of Analytical Methods in Chemistry aims to catalyze knowledge exchange while enhancing the global discourse in analytical science.

Acta Pharmaceutica Sinica B

Publishing Tomorrow's Pharmaceutical Breakthroughs Today
Publisher: INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCESISSN: 2211-3835Frequency: 6 issues/year

Acta Pharmaceutica Sinica B is a prestigious open access journal that has been setting the standard in the field of pharmacology, toxicology, and pharmaceutics since its establishment in 2011. Published by the Institute of Materia Medica, Chinese Academy of Medical Sciences, the journal serves as a vital platform for researchers, professionals, and students seeking to disseminate innovative findings in drug development, pharmaceutical sciences, and therapeutic applications. With an impressive impact factor reflecting its high academic quality, Acta Pharmaceutica Sinica B has achieved Q1 status in the category of Pharmacology, Toxicology and Pharmaceutics as of 2023, ranking #1 out of 80 journals in General Pharmacology. This journal not only focuses on the latest advancements in drug research and formulation but also emphasizes interdisciplinary approaches, fostering collaborations that span various scientific domains. The accessible nature of the journal, combined with its rigorous peer-review process, ensures that crucial insights and breakthroughs reach a global audience swiftly and effectively. For those looking to stay at the forefront of pharmaceutical research, Acta Pharmaceutica Sinica B is an indispensable resource.

DRUG METABOLISM AND DISPOSITION

Shaping the Future of Pharmaceutical Research
Publisher: AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICSISSN: 0090-9556Frequency: 12 issues/year

Drug Metabolism and Disposition is a premier journal published by the American Society for Pharmacology and Experimental Therapeutics, focusing on crucial advancements in the fields of pharmaceutical sciences and pharmacology. Since its inception in 1973, this esteemed journal has established itself as a leading platform for innovative research, earning a prestigious Q1 rating in both Pharmaceutical Science and Pharmacology categories as of 2023. With an impressive Scopus ranking of #52 out of 183 in Pharmaceutical Science and #105 out of 313 in Pharmacology, it occupies a vital place in an increasingly competitive academic landscape. Researchers, professionals, and students alike benefit from its rigorous peer-reviewed articles that delve into drug metabolism processes and their physiological implications, making it an indispensable resource for anyone aiming to advance their understanding of drug disposition and efficacy. This crucial journal contributes significantly to the ongoing dialogue in pharmacology and toxicology, providing insights that help shape future therapeutic strategies and regulatory policies.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Advancing Pharmaceutical Knowledge for a Healthier Tomorrow
Publisher: ELSEVIERISSN: 0928-0987Frequency: 15 issues/year

The European Journal of Pharmaceutical Sciences is a prestigious academic journal dedicated to advancing the field of pharmaceutical science. Published by Elsevier, the journal boasts an impressive impact factor and is categorized in the Q1 quartile for pharmaceutical science as of 2023, signifying its influence and reputation within the academic community. With a Scopus ranking of #20 out of 183 in the fields of pharmacology, toxicology, and pharmaceutics, the journal provides a vital platform for researchers and practitioners to disseminate innovative studies and groundbreaking research that push the boundaries of drug development and delivery. Based in the Netherlands and operating since 1993, the journal seeks to cover a broad scope of topics related to pharmaceutical sciences, encouraging rigorous evaluations and discussions that enhance the understanding and application of this critical field. The absence of open access underscores the commitment to maintaining high scholarly standards, while still offering avenues for libraries and institutions to provide access to cutting-edge research. As the journal converges towards its 2024 milestones, it continuously aims to foster a vibrant exchange of knowledge among its diverse readership, comprising committed researchers, professionals, and students.

International Journal of Pharmaceutical Investigation

Fostering Dialogue on Cutting-Edge Pharmaceutical Practices
Publisher: INPHARM ASSOC, PHCOG NETISSN: 2230-973XFrequency: 4 issues/year

International Journal of Pharmaceutical Investigation, published by INPHARM ASSOC, PHCOG NET, is a premier platform dedicated to advancing the field of pharmaceutical sciences. With the ISSN 2230-973X and E-ISSN 2230-9713, this journal serves as a vital resource for researchers, professionals, and students focused on drug development, formulation, and efficacy. By fostering a rich discourse on innovative pharmaceutical practices and research breakthroughs, the journal plays a critical role in enhancing global health outcomes through groundbreaking scholarly work. The absence of open access allows for selective dissemination of high-quality content, promoting rigorous peer-review processes that uphold academic integrity. Featuring articles that span a diverse range of topics within pharmaceutical sciences, the International Journal of Pharmaceutical Investigation is committed to supporting the ongoing evolution of this dynamic field, making it an essential read for anyone engaged in pharmaceutical research and development.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Advancing pharmaceutical innovation for tropical health.
Publisher: PHARMACOTHERAPY GROUPISSN: 1596-5996Frequency: 2 issues/year

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.

Current Pharmaceutical Analysis

Navigating the Evolving Landscape of Drug Development
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4129Frequency: 6 issues/year

Current Pharmaceutical Analysis, published by Bentham Science Publishers Ltd, is a vital resource for professionals and researchers in the fields of Pharmaceutical Science, Biochemistry, and Molecular Medicine. Established in 2006, this peer-reviewed journal aims to provide a platform for the latest advancements and analytical methodologies in pharmaceutical research and drug development. Over the years, it has garnered attention for its rigorous scrutiny and contributions to the landscape of pharmacology, evidenced by its quartile placements in various categories, most notably Q3 in Pharmaceutical Science. Despite its current rankings placing it in the lower quartile in several disciplines, the journal remains an essential venue for both emerging and established researchers seeking to disseminate their findings. With the widespread accessibility of its articles, researchers, professionals, and students can engage with cutting-edge studies to foster innovation in pharmaceutical analysis. For access to the latest research contributions, readers can explore the digital archive and stay updated on pivotal discussions shaping the future of the pharmaceutical sciences.

European Journal of Pharmacology

Unveiling groundbreaking research in pharmacokinetics and toxicology.
Publisher: ELSEVIERISSN: 0014-2999Frequency: 24 issues/year

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

Turkish Journal of Pharmaceutical Sciences

Connecting Science and Medicine for Better Outcomes
Publisher: GALENOS PUBL HOUSEISSN: 1304-530XFrequency: 6 issues/year

The Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.